Evidence map›Paper›PMID 31242568›Full record

ArticleInternational journal of molecular sciences2019

Reduced Anti-Histone Antibodies and Increased Risk of Rheumatoid Arthritis Associated with a Single Nucleotide Polymorphism in PADI4 in North Americans.

Aisha M Mergaert, Mandar Bawadekar, Thai Q Nguyen, Laura Massarenti, Caitlyn L Holmes, Ryan Rebernick, Steven J Schrodi, Miriam A Shelef

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Frontiers in immunology · 2021
    Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Aisha M MergaertDepartment of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA. mergaert@wisc.edu.
Mandar BawadekarDepartment of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA. mandar.bawadekar@gmail.com.ORCID 0000-0002-4113-8669
Thai Q NguyenDepartment of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA. nguyen45@wisc.edu.
Laura MassarentiInstitute for Inflammation Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital, Rigshospitalet, DK-2100 Copenhagen, Denmark. laura.massarenti@regionh.dk.ORCID 0000-0001-5647-4617
Caitlyn L HolmesDepartment of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA. cherndon@medicine.wisc.edu.
Ryan RebernickDepartment of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA. reberya@gmail.com.
Steven J SchrodiCenter for Precision Medicine Research, Marshfield Clinic Research Institute, Marshfield, WI 54449, USA. schrodi.steven@marshfieldresearch.org.ORCID 0000-0003-2304-8528
Miriam A ShelefDepartment of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA. mshelef@medicine.wisc.edu.ORCID 0000-0002-8842-0303
University of Wisconsin–Madison · USCopenhagen University Hospital · DKMarshfield Clinic · US

Funding

RESEARCH TRAINING IN HEMATOLOGYT32HL007899 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Jane Ellen Churpek · 1998 to 2026
$8.2M
PAD2 and PAD4 in Citrullination, Autoantibodies, and Rheumatoid ArthritisK08AR065500 · NIAMS · UNIVERSITY OF WISCONSIN-MADISON · PI SHELEF, MIRIAM ANNE · 2014 to 2018
$690k
Doris Duke Charitable Foundation 2015099NHLBI NIH HHS T32 HL007899NIAMS NIH HHS K08 AR065500NIH HHS K08AR065500NIH HHS T32HL07899University of Wisconsin School of Medicine and Public Health from the Wisconsin Partnership Program N/A
6 · The paper itself

Abstract

Autoantibodies against citrullinated proteins are a hallmark of rheumatoid arthritis, a destructive inflammatory arthritis. Peptidylarginine deiminase 4 (PAD4) has been hypothesized to contribute to rheumatoid arthritis by citrullinating histones to induce neutrophil extracellular traps (NETs), which display citrullinated proteins that are targeted by autoantibodies to drive inflammation and arthritis. Consistent with this theory, PAD4-deficient mice have reduced NETs, autoantibodies, and arthritis. However, PAD4's role in human rheumatoid arthritis is less clear. Here, we determine if single nucleotide polymorphism rs2240335 in

Indexed as

Disease SusceptibilityPolymorphism, Single NucleotideAllelesArthritis, RheumatoidAutoantibodiesAutoantigensExtracellular TrapsGenotypeHistonesHumansImmunoglobulin GNeutrophilsProtein-Arginine Deiminase Type 4AutoantibodiesAutoantigensHistonesImmunoglobulin GPADI4 protein, humanProtein-Arginine Deiminase Type 4autoantibodyneutrophil extracellular trappeptidylarginine deiminase 4rheumatoid arthritissingle nucleotide polymorphism

Identifiers

PMID31242568
PMCPMC6627847
OpenAlexW2954151907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.